1例女性杂合变异致轻型血友病A的发病机制分析并文献复习

王稳, 崔东艳, 张艾, 等. 1例女性杂合变异致轻型血友病A的发病机制分析并文献复习[J]. 临床血液学杂志, 2023, 36(7): 528-532. doi: 10.13201/j.issn.1004-2806.2023.07.013
引用本文: 王稳, 崔东艳, 张艾, 等. 1例女性杂合变异致轻型血友病A的发病机制分析并文献复习[J]. 临床血液学杂志, 2023, 36(7): 528-532. doi: 10.13201/j.issn.1004-2806.2023.07.013
WANG Wen, CUI Dongyan, ZHANG Ai, et al. The pathogenesis of a female hemophilia A patient with heterozygous variant and literature review[J]. J Clin Hematol, 2023, 36(7): 528-532. doi: 10.13201/j.issn.1004-2806.2023.07.013
Citation: WANG Wen, CUI Dongyan, ZHANG Ai, et al. The pathogenesis of a female hemophilia A patient with heterozygous variant and literature review[J]. J Clin Hematol, 2023, 36(7): 528-532. doi: 10.13201/j.issn.1004-2806.2023.07.013

1例女性杂合变异致轻型血友病A的发病机制分析并文献复习

  • 基金项目:
    HERO(Haemophilia Experience,Results,and Opportunities)基金(No:2018033)
详细信息

The pathogenesis of a female hemophilia A patient with heterozygous variant and literature review

More Information
  • 通过对血友病A(hemophilia A,HA)患者家系进行临床特征分析和分子学检测,探讨女性FⅧ基因杂合变异致轻型HA的发病机制,并通过检索国际FⅧ基因变异数据库进行相关文献复习。结果显示先证者FⅧ:C 0.3%,为重型HA患者,伴有抑制物产生,基因变异检测发现先证者存在大片段缺失变异(c.delexons14_22),此变异为已知的致病性变异,目前国内外报道了6例患者,均为重型HA,其中5例报道了抑制物产生,1例患者未对抑制物进行描述。先证者母亲为大片段缺失变异的杂合变异,FⅧ:C 13%,为轻型HA,未见抑制物形成;X染色体失活检测发现该母亲的正常X染色体比携带FⅧ基因变异的X染色体表达活性低。大片段缺失变异(c.delexons14_22)可引起重型HA,且与抑制物产生高度相关。女性杂合变异致轻型HA的机制可解释为X染色体表达存在非随机不平衡失活。
  • 加载中
  • 图 1  MLPA的检测结果

    图 2  凝胶电泳图

    图 3  PCR产物毛细血管电泳图

  • [1]

    Mahlangu J, Oldenburg J, Paz-Priel I, et al. Emicizumab prophylaxis in patients who have hemophilia A without inhibitors[J]. N Engl J Med, 2018, 379(9): 811-822. doi: 10.1056/NEJMoa1803550

    [2]

    Hirayama AB, Silva AKCD, Rocha JS, et al. Prevalence of symptoms in hemophilia carriers in comparison with the general population: a systematic review[J]. Hematol Transfus Cell Ther, 2019, 41(4): 349-355. doi: 10.1016/j.htct.2019.02.006

    [3]

    Al-Huniti A, Sharathkumar A, Krantz M, et al. Discrepant hemophilia A: an underdiagnosed disease entity[J]. Am J Clin Pathol, 2020, 154(1): 78-87. doi: 10.1093/ajcp/aqaa024

    [4]

    Seaman CD, Xavier F, Ragni MV. Hemophilia A(factor Ⅷ deficiency)[J]. Hematol Oncol Clin North Am, 2021, 35(6): 1117-1129. doi: 10.1016/j.hoc.2021.07.006

    [5]

    Franchini M, Mannucci PM. The history of hemophilia[J]. Semin Thromb Hemost, 2014, 40(5): 571-576. doi: 10.1055/s-0034-1381232

    [6]

    Mannucci PM. Hemophilia therapy: the future has begun[J]. Haematologica, 2020, 105(3): 545-553. doi: 10.3324/haematol.2019.232132

    [7]

    张磊, 代新岳. 血友病基因治疗临床研究进展[J]. 临床血液学杂志, 2022, 35(7): 464-468. doi: 10.13201/j.issn.1004-2806.2022.07.003 https://lcxy.whuhzzs.com/article/doi/10.13201/j.issn.1004-2806.2022.07.003

    [8]

    Shinozawa K, Amano K, Hagiwara T, et al. Genetic analysis of carrier status in female members of Japanese hemophilia families[J]. J Thromb Haemost, 2021, 19(6): 1493-1505. doi: 10.1111/jth.15301

    [9]

    Paroskie A, Gailani D, DeBaun MR, et al. A cross-sectional study of bleeding phenotype in haemophilia A carriers[J]. Br J Haematol, 2015, 170(2): 223-228. doi: 10.1111/bjh.13423

    [10]

    Garagiola I, Mortarino M, Siboni SM, et al. X Chromosome inactivation: a modifier of factor Ⅷ and Ⅸ plasma levels and bleeding phenotype in Haemophilia carriers[J]. Eur J Hum Genet, 2021, 29(2): 241-249. doi: 10.1038/s41431-020-00742-4

    [11]

    中华医学会血液学分会血栓与止血学组, 中国血友病协作组. 凝血因子Ⅷ/Ⅸ抑制物诊断与治疗中国指南(2018年版)[J]. 中华血液学杂志, 2018, 39(10): 793-799. doi: 10.3760/cma.j.issn.0253-2727.2018.10.001

    [12]

    Spena S, Garagiola I, Cannavò A, et al. Prediction of factor Ⅷ inhibitor development in the SIPPET cohort by mutational analysis and factor Ⅷ antigen measurement[J]. J Thromb Haemost, 2018, 16(4): 778-790. doi: 10.1111/jth.13961

    [13]

    Cygan PH, Kouides PA. Regulation and importance of factor ⅧI levels in hemophilia A carriers[J]. Curr Opin Hematol, 2021, 28(5): 315-322. doi: 10.1097/MOH.0000000000000667

    [14]

    Plug I, Mauser-Bunschoten EP, Bröcker-Vriends AHJT, et al. Bleeding in carriers of hemophilia[J]. Blood, 2006, 108(1): 52-56. doi: 10.1182/blood-2005-09-3879

    [15]

    Miller CH, Bean CJ. Genetic causes of haemophilia in women and girls[J]. Haemophilia, 2021, 27(2): e164-e179.

    [16]

    d'Oiron R, O'Brien S, James AH. Women and girls with haemophilia: lessons learned[J]. Haemophilia, 2021, 27(Suppl 3): 75-81.

    [17]

    Loda A, Collombet S, Heard E. Gene regulation in time and space during X-chromosome inactivation[J]. Nat Rev Mol Cell Biol, 2022, 23(4): 231-249.

    [18]

    Furlan G, Galupa R. Mechanisms of choice in X-chromosome inactivation[J]. Cells, 2022, 11(3): 535. doi: 10.3390/cells11030535

    [19]

    Wang D, Tang L, Wu YF, et al. Abnormal X chromosome inactivation and tumor development[J]. Cell Mol Life Sci, 2020, 77(15): 2949-2958. doi: 10.1007/s00018-020-03469-z

    [20]

    Pereira G, Dória S. X-chromosome inactivation: implications in human disease[J]. J Genet, 2021, 100: 63. doi: 10.1007/s12041-021-01314-1

    [21]

    Dossin F, Heard E. The molecular and nuclear dynamics of X-chromosome inactivation[J]. Cold Spring Harb Perspect Biol, 2022, 14(4): a040196.

    [22]

    Shvetsova E, Sofronova A, Monajemi R, et al. Skewed X-inactivation is common in the general female population[J]. Eur J Hum Genet, 2019, 27(3): 455-465. doi: 10.1038/s41431-018-0291-3

    [23]

    Posynick BJ, Brown CJ. Escape from X-chromosome inactivation: an evolutionary perspective[J]. Front Cell Dev Biol, 2019, 7: 241. doi: 10.3389/fcell.2019.00241

    [24]

    Vianna EQ, Piergiorge RM, Gonçalves AP, et al. Understanding the landscape of X-linked variants causing intellectual disability in females through extreme X chromosome inactivation skewing[J]. Mol Neurobiol, 2020, 57(9): 3671-3684. doi: 10.1007/s12035-020-01981-8

    [25]

    Dardik R, Avishai E, Lalezari S, et al. Molecular mechanisms of skewed X-chromosome inactivation in female hemophilia patients-lessons from wide genome analyses[J]. Int J Mol Sci, 2021, 22(16): 9074. doi: 10.3390/ijms22169074

  • 加载中

(3)

计量
  • 文章访问数:  846
  • PDF下载数:  216
  • 施引文献:  0
出版历程
收稿日期:  2022-06-09
修回日期:  2023-04-16
刊出日期:  2023-07-01

目录